STOCK TITAN
  1. Home
  2. Sec-filings
  3. NHTC
  4. [8-K] NATURAL HEALTH TRENDS CORP Reports Material Event

Natural Health Trends Corp. (NASDAQ: NHTC) posts Q2 loss, resumes buybacks

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Natural Health Trends Corp. reported weaker results for the quarter ended June 30, 2026. Net sales were $7,603 thousand, down from $9,813 thousand a year earlier, leading to a net loss of $451 thousand versus net income of $15 thousand in the prior-year quarter. For the first six months of 2026, net sales were $16,809 thousand and the company recorded a net loss of $605 thousand, compared with net income of $137 thousand in the first half of 2025.

Total cash, cash equivalents and marketable securities were $18.6 million at June 30, 2026, down from $28.9 million at December 31, 2025, largely due to share repurchases and dividends. Operating activities used $2,161 thousand of cash in the first half. The Board authorized resuming stock repurchases, with $15.9 million remaining under the program. Management cited a challenging environment in China, regulatory uncertainty, and member conduct issues that disrupted business, while highlighting restructuring savings of about $300,000 in the quarter and over $600,000 year-to-date.

Positive

  • Board resumes stock repurchases with approximately $15.9 million remaining under the existing authorization, signaling continued willingness to return capital to shareholders.
  • Restructuring program delivering savings, generating roughly $300,000 in margin-related cost reductions in Q2 2026 and more than $600,000 year-to-date.

Negative

  • Revenue decline and swing to loss: Q2 2026 net sales fell to $7,603 thousand from $9,813 thousand, with a net loss of $451 thousand versus prior-year profitability.
  • Cash position down sharply: total cash, cash equivalents and marketable securities fell to $18.6 million from $28.9 million, driven by share repurchases and dividends alongside a $2,161 thousand operating cash outflow.
  • Business disruption from China headwinds and member conduct, as management cited regulatory uncertainty and policy violations that adversely affected second-quarter revenue and operating results.

Filing Explained

The filing reports that Natural Health Trends repurchased $5,870 thousand of common stock during the six months ended June 30, 2026, while weighted-average shares fell to 8,578 thousand from 11,493 thousand a year earlier; the remaining $15.9 million authorization is capacity, not a committed purchase.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Net sales Q2 2026 $7,603 thousand Three months ended June 30, 2026
Net income (loss) Q2 2026 $(451) thousand Three months ended June 30, 2026
Net sales H1 2026 $16,809 thousand Six months ended June 30, 2026
Net income (loss) H1 2026 $(605) thousand Six months ended June 30, 2026
Cash, cash equivalents and marketable securities $18.6 million Balance at June 30, 2026; down from $28.9 million at December 31, 2025
Remaining stock repurchase authorization $15.9 million Authorized by Board under existing stock repurchase program
Restructuring savings Q2 2026 $300,000 Operating and margin-related cost savings in the quarter
Net cash used in operating activities H1 2026 $(2,161) thousand Six months ended June 30, 2026
stock repurchase program financial
"authorized the resumption of share repurchases under its existing stock repurchase program, with $15.9 million"
A stock repurchase program is when a company buys back its own shares from the market. This can make each remaining share more valuable and shows that the company believes its stock is a good investment. It’s like a business treating its shares like a limited resource, hoping to boost confidence and share prices.
deferred revenue financial
"Deferred revenue | | | 4,205 | | | | 5,574 |"
Cash a company has already received for goods or services it has promised but not yet delivered; it's recorded as a liability because the company still owes that product, service, or future revenue recognition. For investors, deferred revenue signals upcoming work or deliveries that will convert into reported sales over time and affects short-term obligations, cash flow quality, and how quickly a firm can grow recognized revenue—think of it like prepaid subscriptions or gift cards a business must honor later.
Amounts held in eWallets financial
"Amounts held in eWallets | | | 2,606 | | | | 2,838 |"
operating lease right-of-use assets financial
"Operating lease right-of-use assets | | | 2,589 | | | | 1,869 |"
An operating lease right-of-use (ROU) asset is an accounting entry that shows the value of a leased item you have the legal right to use—like a building, vehicle, or equipment—recorded on a company’s balance sheet along with the corresponding lease obligation. Investors care because it adds to reported assets and liabilities, changing measures like leverage and return on assets much like bringing a long-term rental onto the company’s financial snapshot, which can affect credit terms and valuation.
forward-looking statements regulatory
"Forward-looking statements in this press release do not constitute guarantees of future performance."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Net sales Q2 2026 $7,603 thousand down from $9,813 thousand in Q2 2025
Net income (loss) Q2 2026 $(451) thousand down from net income of $15 thousand in Q2 2025
Net sales H1 2026 $16,809 thousand down from $20,550 thousand in H1 2025
Net income (loss) H1 2026 $(605) thousand down from net income of $137 thousand in H1 2025
Guidance

Management highlighted ongoing restructuring benefits, expected additional cost savings in the second half of 2026, and continued investment in products and technology amid challenging conditions in China and regulatory uncertainty.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

false 0000912061 0000912061 2026-07-29 2026-07-29
UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
July 29, 2026
Date of Report (Date of earliest event reported)
 
 NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
 
Delaware
001-36849
59-2705336
(State or other jurisdiction of incorporation)        
(Commission File Number)  
(IRS Employer Identification No.)
 
 609 Deep Valley Drive, Suite 395 Rolling Hills Estates, California, 90274
(Address of principal executive offices, including zip code)
 
(310) 541-0888
(Registrant’s telephone number, including area code)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Exchange Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
NHTC
The NASDAQ Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company     ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐
 
 
 
 
Item 2.02 Results of Operations and Financial Condition.
 
On July 29, 2026, Natural Health Trends Corp. issued an earnings release announcing its results for the quarter ended June 30, 2026. The press release is attached hereto as exhibit 99.1.
 
Item 9.01 Financial Statements and Exhibits.
 
 
(d)
Exhibits.
  
    99.1 Press Release of Natural Health Trends Corp. dated July 29, 2026
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: July 29, 2026
 
NATURAL HEALTH TRENDS CORP.
  
 
 
 
  
 
 
 
  
 
By:
/s/ Timothy S. Davidson
  
 
 
Timothy S. Davidson
  
 
 
Senior Vice President and Chief Financial Officer
  
 
 

Exhibit 99.1

 

Natural Health Trends Reports Second Quarter 2026 Financial Results

 

  – Company preparing for its 25th anniversary celebration in Hong Kong in the next quarter
  – Board of Directors authorized resuming stock repurchases, with approximately $16 million available  
  – Restructuring program generated approximately $300,000 of operating and other margin-related cost savings during the quarter
  – Year-to-date savings from the restructuring program have exceeded $600,000

 

LOS ANGELES – July 29, 2026 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended June 30, 2026.

 

Second Quarter 2026 Financial Results

 

 

•

Revenue of $7.6 million decreased 23% compared to $9.8 million in the second quarter of 2025.

 

 

•

Operating loss was $643,000 compared to $333,000 in the second quarter of 2025.

 

 

•

Net loss was $451,000, or $0.05 per diluted share, compared to net income of $15,000, or breakeven per diluted share, in the second quarter of 2025. 

 

 

•

The number of Active Members1 was 26,000 at June 30, 2026 compared to 26,650 at December 31, 2025 and 29,260 at June 30, 2025.

 

 

1

Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

 

Year-to-Date 2026 Financial Results

 

 

•

Revenue of $16.8 million decreased 18% compared to $20.6 million in the first six months of 2025.

 

 

•

Operating loss was $1.1 million compared to $678,000 in the first six months of 2025.

 

 

•

Net loss was $605,000, or $0.06 per diluted share, compared to net income of $137,000, or $0.01 per diluted share, in the first six months of 2025.

 

Management Commentary

 

 “The operating environment remains challenging. In China, consumers continue to be cautious about spending and investing, while regulatory uncertainty caused some members to pause activities during the quarter. We also identified conduct by certain members that violated the Company's Hong Kong policies, procedures and professional code of conduct. These activities disrupted our business and adversely affected second quarter revenue and operating results. At the same time, the restructuring program implemented late last year has already reduced costs and streamlined our organization, and we expect to realize additional savings in the second half of the year. We are also developing programs and campaigns to more aggressively support our members while continuing to invest in products and technology,” commented Chris Sharng, President of Natural Health Trends Corp.

 

Mr. Sharng continued, “We're looking forward to celebrating our 25th anniversary in Hong Kong in the third quarter with a full lineup of prizes and rewards that customers can qualify for leading up to and during the event. We expect more than 1,000 attendees from around the world and plan to reconfirm our strategies and commitment at this event.”

 

 

 

1
 

 

Balance Sheet and Cash Flow

 

 

•

Net cash used in operating activities was $2.2 million in the first six months of 2026 compared to $5.2 million in the first six months of 2025.
 

•

Total cash, cash equivalents and marketable securities were $18.6 million at June 30, 2026, down from $28.9 million at December 31, 2025 primarily due to the repurchase of shares of common stock and dividends paid during the first six months of 2026.
  • The Company's Board of Directors has authorized the resumption of share repurchases under its existing stock repurchase program, with $15.9 million remaining available, subject to market conditions and other relevant considerations.

 

Second Quarter 2026 Financial Results Conference Call

 

Management will host a conference call to discuss the second quarter 2026 financial results today, Wednesday, July 29, 2026 at 11:30 a.m. Eastern Time. The conference call details are as follows:

 

Date:

Wednesday, July 29, 2026

Time:

11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time

Dial-in:

1-800-330-6730

Participant ID:

749478

 

For those unable to participate during the live broadcast, a replay of the call will be available on the Company's Investor Relations website at https://ir.naturalhealthtrendscorp.

 

About Natural Health Trends Corp.

 

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

 

Forward-Looking Statements

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Forward-looking statements in this press release include statements relating to the anticipated effect of restructuring activities, including expected operational efficiencies and cost savings resulting therefrom, statements regarding technology investments, future growth and profitability, and statements relating to future dividends, the declaration and payment of which will be at the sole discretion of the Company's Board of Directors. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 20, 2026 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

 

2
 

 

CONTACT:

 

Scott Davidson

Senior Vice President and Chief Financial Officer

Natural Health Trends Corp.

Tel (U.S.): 310-541-0888

investor.relations@nhtglobal.com

 

3
 

 

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data) 

 

   

June 30, 2026

    

December 31, 2025

  
   

(Unaudited)

          

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 9,501     $ 6,813  

Marketable securities

     9,121       22,060  

Inventories

     2,049       2,047  

Other current assets

     3,033       3,274  

Total current assets

     23,704       34,194  

Property and equipment, net

     570       153  

Operating lease right-of-use assets

     2,589       1,869  

Deferred tax asset

     288       289  

Other assets

     2,059       1,923  

Total assets

   $ 29,210     $ 38,428  

LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Accounts payable

   $ 964     $ 555  

Accrued commissions

     1,741       1,958  

Other accrued expenses

     1,222       1,438  

Deferred revenue

     4,205       5,574  

Amounts held in eWallets

     2,606       2,838  

Operating lease liabilities

     860       869  

Other current liabilities

     341       456  

Total current liabilities

     11,939       13,688  

Deferred tax liability

     179       180  

Operating lease liabilities

     1,890       1,131  

Total liabilities

     14,008       14,999  

Stockholders’ equity:

                

Preferred stock

     —       —  

Common stock

     13       13  

Additional paid-in capital

     85,033       85,033  

Accumulated deficit

     (38,757 )     (36,436 )

Accumulated other comprehensive loss

     (728 )     (784 )

Treasury stock, at cost

     (30,359 )     (24,397 )

Total stockholders’ equity

     15,202       23,429  

Total liabilities and stockholders’ equity

   $ 29,210     $ 38,428  

 

4
 

 

NATURAL HEALTH TRENDS CORP. 

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(In thousands, except per share data)

 

   

Three Months Ended June 30,

    

Six Months Ended June 30,

  
   

2026

    

2025

    

2026

    

2025

  

Net sales

   $ 7,603     $ 9,813     $ 16,809     $ 20,550  

Cost of sales

     1,882       2,558       4,185       5,390  

Gross profit

     5,721       7,255       12,624       15,160  

Operating expenses:

                                

Commissions expense

     3,111       4,012       6,964       8,500  

Selling, general and administrative expenses

     3,253       3,576       6,777       7,338  

Total operating expenses

     6,364       7,588       13,741       15,838  

Loss from operations

     (643 )     (333 )     (1,117 )     (678 )

Other income, net

     190       348       485       813  

Income (loss) before income taxes

     (453 )     15       (632 )     135  

Income tax benefit

     (2 )     —       (27 )     (2 )

Net income (loss)

   $ (451 )   $ 15     $ (605 )   $ 137  

Net income (loss) per common share:

                                

Basic

   $ (0.05 )   $ 0.00     $ (0.06 )   $ 0.01  

Diluted

   $ (0.05 )   $ 0.00     $ (0.06 )   $ 0.01  

Weighted average common shares outstanding:

                                

Basic

     8,578       11,493       9,356       11,489  

Diluted

     8,578       11,497       9,356       11,496  

 

5
 

 

NATURAL HEALTH TRENDS CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(In thousands)

 

   

Six Months Ended June 30,

  
   

2026

    

2025

  

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net income (loss)

   $ (605 )   $ 137  

Adjustments to reconcile net income (loss) to net cash used in operating activities:

                

Depreciation and amortization

     34       59  

Net accretion of marketable securities

     (36 )     (214 )

Share-based compensation

     —       68  

Noncash lease expense

     599       573  

Deferred income taxes

     —       (3 )

Changes in assets and liabilities:

                

Inventories

     (27 )     525  

Other current assets

     358       402  

Other assets

     (144 )     (334 )

Accounts payable

     376       65  

Accrued commissions

     (202 )     (194 )

Other accrued expenses

     (276 )     (110 )

Deferred revenue

     (1,330 )     (311 )

Amounts held in eWallets

     (210 )     (170 )

Operating lease liabilities

     (585 )     (561 )

Other current liabilities

     (113 )     (5,083 )

Net cash used in operating activities

     (2,161 )     (5,151 )

CASH FLOWS FROM INVESTING ACTIVITIES:

                

Purchases of property and equipment

     (440 )     (20 )

Purchases of marketable securities

     (8,709 )     (27,552 )

Proceeds from maturities of marketable securities

     21,566       34,215  

Net cash provided by investing activities

     12,417       6,643  

CASH FLOWS FROM FINANCING ACTIVITIES:

                

Repurchase of common stock

     (5,870 )     —  

Dividends paid

     (1,716 )     (4,606 )

Net cash used in financing activities

     (7,586 )     (4,606 )

Effect of exchange rates on cash, cash equivalents and restricted cash

     17       118  

Net increase (decrease) in cash, cash equivalents and restricted cash

     2,687       (2,996 )

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period

     6,820       13,567  

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period

   $ 9,507     $ 10,571  

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:

                

Right-of-use assets obtained in exchange for operating lease liabilities

   $ 1,356     $ 112  

Direct costs incurred to repurchase common stock

   $ 92     $ —  

 

6

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

5 documents

Press Releases

Other Documents